The company's founders are led by world-renowned cell biologist and Dean of Westlake University’s School of Life Sciences Professor Yu Hongtao; with Professors Hu Qi and Huang Jing, also of the School of Life Sciences. This team has coupled deep expertise of their own field with inter-disciplinary technical solutions spanning cell biology, structural biology, medicinal chemistry, and artificial intelligence, to create a synergistic innovation system (from target screening to structural analysis, molecular design, drug synthesis, formulation optimization, and function validation), aiming to develop novel drug solutions to some of the most serious diseases.